论文部分内容阅读
目的:分析慢性阻塞性肺疾病急性加重期采用热毒宁注射液治疗的临床疗效。方法:选取慢性阻塞性肺疾病急性加重期患者70例,随机分为两组,对照组33例给予常规治疗,观察组37例在常规治疗基础上给予热毒宁注射液治疗,对比两组治疗效果及不良反应。结果:两组患者治疗期间无严重不良反应,观察组治疗总有效率显著高于对照组(P<0.05);治疗后两组患者肺功能指标显著升高,且观察组肺功能指标显著高于对照组(P<0.05)。结论:在慢性阻塞性肺疾病急性加重期采用热毒宁注射液治疗效果显著,用药安全性高,值得推广。
OBJECTIVE: To analyze the clinical efficacy of Renduining injection in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: Seventy patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) were randomly divided into two groups. The control group (33 cases) was given routine treatment. The observation group (37 cases) was given Radixonin injection on the basis of routine treatment. Effect and adverse reaction. Results: The two groups had no serious side effects during the treatment, the total effective rate in the observation group was significantly higher than that in the control group (P <0.05). After the treatment, the pulmonary function indexes in the two groups were significantly increased, and the lung function indexes in the observation group were significantly higher than those in the control group Control group (P <0.05). Conclusions: The treatment of Rendunning injection in the acute exacerbation of chronic obstructive pulmonary disease is effective and safe to treat. It is worth to be popularized.